Cargando…
Correction: Targeting Hsp27/eIF4E interaction with phenazine compound: a promising alternative for castration-resistant prostate cancer treatment
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6033366/ https://www.ncbi.nlm.nih.gov/pubmed/29983898 http://dx.doi.org/10.18632/oncotarget.25683 |
| _version_ | 1783337687519854592 |
|---|---|
| author | Ziouziou, Hajer Andrieu, Claudia Laurini, Erik Karaki, Sara Fermeglia, Maurizio Oueslati, Ridha Taieb, David Camplo, Michel Siri, Olivier Pricl, Sabrina Katsogiannou, Maria Rocchi, Palma |
| author_facet | Ziouziou, Hajer Andrieu, Claudia Laurini, Erik Karaki, Sara Fermeglia, Maurizio Oueslati, Ridha Taieb, David Camplo, Michel Siri, Olivier Pricl, Sabrina Katsogiannou, Maria Rocchi, Palma |
| author_sort | Ziouziou, Hajer |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6033366 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | Impact Journals LLC |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-60333662018-07-08 Correction: Targeting Hsp27/eIF4E interaction with phenazine compound: a promising alternative for castration-resistant prostate cancer treatment Ziouziou, Hajer Andrieu, Claudia Laurini, Erik Karaki, Sara Fermeglia, Maurizio Oueslati, Ridha Taieb, David Camplo, Michel Siri, Olivier Pricl, Sabrina Katsogiannou, Maria Rocchi, Palma Oncotarget Correction Impact Journals LLC 2018-06-19 /pmc/articles/PMC6033366/ /pubmed/29983898 http://dx.doi.org/10.18632/oncotarget.25683 Text en Copyright: © 2018 Ziouziou et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
| spellingShingle | Correction Ziouziou, Hajer Andrieu, Claudia Laurini, Erik Karaki, Sara Fermeglia, Maurizio Oueslati, Ridha Taieb, David Camplo, Michel Siri, Olivier Pricl, Sabrina Katsogiannou, Maria Rocchi, Palma Correction: Targeting Hsp27/eIF4E interaction with phenazine compound: a promising alternative for castration-resistant prostate cancer treatment |
| title | Correction: Targeting Hsp27/eIF4E interaction with phenazine compound: a promising alternative for castration-resistant prostate cancer treatment |
| title_full | Correction: Targeting Hsp27/eIF4E interaction with phenazine compound: a promising alternative for castration-resistant prostate cancer treatment |
| title_fullStr | Correction: Targeting Hsp27/eIF4E interaction with phenazine compound: a promising alternative for castration-resistant prostate cancer treatment |
| title_full_unstemmed | Correction: Targeting Hsp27/eIF4E interaction with phenazine compound: a promising alternative for castration-resistant prostate cancer treatment |
| title_short | Correction: Targeting Hsp27/eIF4E interaction with phenazine compound: a promising alternative for castration-resistant prostate cancer treatment |
| title_sort | correction: targeting hsp27/eif4e interaction with phenazine compound: a promising alternative for castration-resistant prostate cancer treatment |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6033366/ https://www.ncbi.nlm.nih.gov/pubmed/29983898 http://dx.doi.org/10.18632/oncotarget.25683 |
| work_keys_str_mv | AT ziouziouhajer correctiontargetinghsp27eif4einteractionwithphenazinecompoundapromisingalternativeforcastrationresistantprostatecancertreatment AT andrieuclaudia correctiontargetinghsp27eif4einteractionwithphenazinecompoundapromisingalternativeforcastrationresistantprostatecancertreatment AT laurinierik correctiontargetinghsp27eif4einteractionwithphenazinecompoundapromisingalternativeforcastrationresistantprostatecancertreatment AT karakisara correctiontargetinghsp27eif4einteractionwithphenazinecompoundapromisingalternativeforcastrationresistantprostatecancertreatment AT fermegliamaurizio correctiontargetinghsp27eif4einteractionwithphenazinecompoundapromisingalternativeforcastrationresistantprostatecancertreatment AT oueslatiridha correctiontargetinghsp27eif4einteractionwithphenazinecompoundapromisingalternativeforcastrationresistantprostatecancertreatment AT taiebdavid correctiontargetinghsp27eif4einteractionwithphenazinecompoundapromisingalternativeforcastrationresistantprostatecancertreatment AT camplomichel correctiontargetinghsp27eif4einteractionwithphenazinecompoundapromisingalternativeforcastrationresistantprostatecancertreatment AT siriolivier correctiontargetinghsp27eif4einteractionwithphenazinecompoundapromisingalternativeforcastrationresistantprostatecancertreatment AT priclsabrina correctiontargetinghsp27eif4einteractionwithphenazinecompoundapromisingalternativeforcastrationresistantprostatecancertreatment AT katsogiannoumaria correctiontargetinghsp27eif4einteractionwithphenazinecompoundapromisingalternativeforcastrationresistantprostatecancertreatment AT rocchipalma correctiontargetinghsp27eif4einteractionwithphenazinecompoundapromisingalternativeforcastrationresistantprostatecancertreatment |